Day Two: Tuesday, June 2, 2026 - ET (Eastern Time, GMT-05:00)
- Rosy Sasso - President, PBECC - Privacy, Business Ethics & Compliance Consulting
The role of commercial leaders’ in setting the Ethical & Compliance tone in an organization, on how such integrity focused efforts translate to reputational excellence
What do Compliance teams have to put in place today to withstand future scrutiny?
How can Compliance leaders ensure they are in better shape to address future challenges and improve resilience?
- James Brodie - Former General Manager, Canada, Johnson & Johnson Medtech
- Stephan Ekmekjian - Health Care Compliance Officer, Medical Devices Canada, Johnson & Johnson Medtech Canada Inc.
- Hear from leading experts on the ethical and legal considerations of the use of AI in Canadian healthcare.
- Receive an update on Canadian and relevant international AI governance practices
- Understand the responsibility and liability industry assumes in incorporating AI in their patient and consumer solutions. The path forward - exciting possibilities and the anticipated benefits for Canadian patients and consumers as well as key risks to consider
- How can Legal, Ethics and Compliance professionals better prepare for the future with AI and ensure an ethical and responsible development and deployment of AI
- Liam Campbell - Legal Counsel, Data Protection & AI Officer, Boehringer Ingelheim
- Lina Combariza - Compliance Associate Director, Amgen
- Utilizing compliance expertise to enhance decision-making and support business growth initiatives
- Innovative ways to impact and integrate yourself into the business: developing a proactive solution orientated approach
- Developing essential capabilities: as technology and requirements evolve, what are the essential skills and capabilities for Compliance functions in 2026 and beyond?
- Evaluating current team competencies against emerging needs
- Karen Southin - Ethics and Compliance Officer, Pharmacosmos
- Rufina Ho - Compliance Officer, Corporate Compliance Program Operations Lead, Biogen
- Ratika Gandhi - Head of Legal & Compliance, LACAN (Canada and Latin America), Alcon
- Lisa Noble - Ethics and Compliance Lead, North America, Bausch & Lomb
This extended practical session will work through hypothetical case study scenarios using audience participation to identify key decisions points and indicators of risk and solutions
- How to conduct a compliance investigation: practical tips to improve your investigation case management, planning, evidence collection, interviewing techniques and report writing
- Conducting effective internal investigations through structured data collection, analysis, confidentiality controls, and clear reporting
- Best practice approaches: sharing common trip points, identifying when to call outside counsel and ideas on how conduct interview
- Coordinate smoothly with business leaders and internal stakeholders by defining roles, aligning communication, and managing dual local–global compliance requirements
- Shane D’Souza - Partner, McCarthy Tétrault
- Genevieve St-Cyr Larkin - Partner, McCarthy Tétrault
- Khadeeja Ahsan - Manager, Global Business Ethics and Compliance Investigator, Apotex Inc.
Working through the fundamentals of good data:
- Who: internal resources to engage, train and help influence change
- What: practical considerations for gathering data from real world evidence and field interactions to system reports
Privacy essentials: privacy‑aligned data governance practices that ensure accuracy and reliability
- Manpreet Singh - Partner, Norton Rose Fulbright Canada
- Xavier Pouts - Privacy & Ai Ethics Officer, Sanofi
Patient organizations (POs) are essential partners in improving care, informing research, and supporting patients—but these relationships carry unique compliance and legal sensitivities, particularly around undue influence and independence, transparency/disclosure, and patient data/privacy. Panelists will share a practical risk map and a control framework that enables meaningful collaboration while protecting trust. The discussion will pressure-test real-world scenarios and close with emerging trends shaping the next generation of compliant patient engagement—framed around three core questions: What’s the biggest compliance risk in PO engagement? What controls matter most for Canada? When do you say no?
